多病共存患者潜在不适当用药 prevalence:LESS-CHRON与STOPPFrail标准对比
本研究为单中心横断面观察性研究,在门诊多病共存多重用药老年患者中比较LESS-CHRON与STOPPFrail两种基于标准的减药工具识别潜在不适当用药(PIM)的 prevalence。两者均与入组时处方药数量显著相关,LESS-CHRON与Profund、Barthel及Frail-VIG指数显著相关。
要点
- LESS-CHRON识别PIM数量多于STOPPFrail(158 vs 127)。
- 两工具均与处方药数量显著相关,LESS-CHRON另与Profund、Barthel、Frail-VIG相关。
- LESS-CHRON检测潜力更大,STOPPFrail在部分治疗领域有互补性。
核心结论
- 两种工具均能识别研究人群中可减停的PIM,LESS-CHRON在分析亚组中检测潜力更大,STOPPFrail在LESS-CHRON未覆盖的其他治疗领域具有一定互补性。
研究设计与样本
- 单中心横断面观察性研究,在门诊内科随访患者中通过电子健康卡系统回顾病史和药物治疗,识别STOPPFrail和LESS-CHRON标准下的PIM。
主要发现
- LESS-CHRON识别PIM总数为158个,STOPPFrail识别127个。
- LESS-CHRON的27条标准中8条(29.6%)不适用,STOPPFrail的25条标准中15条不适用。
- 两种工具均与入组时处方药数量显著相关(Spearman rho相关分析)。
- Profund、Barthel和Frail-VIG指数仅与LESS-CHRON显示显著相关。
关键数值与推荐
- LESS-CHRON识别PIM 158个,STOPPFrail识别127个。
- LESS-CHRON标准不适用比例29.6%(8/27),STOPPFrail不适用15/25。
- 中位处方药数量14.4种(四分位距12-17)。
临床怎么用
- 在门诊多病共存多重用药老年患者中,可优先使用LESS-CHRON识别可减停PIM,并结合STOPPFrail补充评估其未覆盖的治疗领域。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: LESS-CHRON (List of Evidence-Based Deprescribing for Chronic Patients) and STOPPFrail (Screening Tool of Older Persons' Prescriptions in Frail adults with limited life expectancy) are criterion-based deprescribing tools. This study aimed to identify the prevalence of potentially inappropriate medications (PIMs) with these tools in an outpatient, polymedicated, older population with multimorbidity. DESIGN: Single-center cross-sectional observational study. SETTING AND PARTICIPANTS: PIMs and criteria subject to deprescribing identified by each tool were collected in patients who were being followed up on outpatient internal medicine consultation. METHODS: PIMs were identified by STOPPFrail and LESS-CHRON criteria reviewing medical histories and pharmacologic treatments of the patients in the electronic health card system. Sociodemographic, clinical, and pharmacologic variables were recorded. A correlation analysis between treatment tools and clinical values was performed using the nonparametric Spearman rho correlation. RESULTS: Eighty-three patients with a median of 14.4 (interquartile range 12-17) prescribed drugs were included. The total number of PIMs identified with LESS-CHRON was 158 vs 127 with STOPPFrail. Eight of the 27 criteria (29.6%) for LESS-CHRON and 15 of the 25 for STOPPFrail were found to be not applicable. A significant correlation was obtained for both tools with the number of prescribed drugs at the time of inclusion. The Profund, Barthel, and Frail-VIG index only showed a significant correlation with LESS-CHRON. CONCLUSION AND IMPLICATIONS: Both tools have shown the capacity to identify PIMs that can be deprescribed in the population studied. However, LESS-CHRON appears to have a greater detection potential in the subgroup of patients analyzed. STOPPFrail brings a certain complementarity in other areas of therapy not covered by LESS-CHRON.
引用
- Mejías-Trueba M, Rodríguez-Pérez A, Sotillo-Sánchez I, et al. Prevalence of Potentially Inappropriate Medications in Patients With Multimorbidity According to LESS-CHRON and STOPPFrail Criteria. J Am Med Dir Assoc. 2023. PMID: 36608936. doi:10.1016/j.jamda.2022.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。